Canada markets closed

Genix Pharmaceuticals Corporation (GENX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.05500.0000 (0.00%)
At close: 09:30AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 3.26M
Enterprise Value 3.82M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)300.60
Price/Book (mrq)1.04
Enterprise Value/Revenue 352.84
Enterprise Value/EBITDA -1.02

Trading Information

Stock Price History

Beta (5Y Monthly) -0.60
52-Week Change 350.00%
S&P500 52-Week Change 321.23%
52 Week High 30.0800
52 Week Low 30.0200
50-Day Moving Average 30.0540
200-Day Moving Average 30.0490

Share Statistics

Avg Vol (3 month) 316.38k
Avg Vol (10 day) 317.1k
Shares Outstanding 559.22M
Implied Shares Outstanding 664.61M
Float 833.55M
% Held by Insiders 143.35%
% Held by Institutions 10.00%
Shares Short (Mar 28, 2024) 41
Short Ratio (Mar 28, 2024) 40
Short % of Float (Mar 28, 2024) 4N/A
Short % of Shares Outstanding (Mar 28, 2024) 40.00%
Shares Short (prior month Feb 29, 2024) 4366

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Oct 31, 2023
Most Recent Quarter (mrq)Jan 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-56,860.57%

Management Effectiveness

Return on Assets (ttm)-18.49%
Return on Equity (ttm)-476.20%

Income Statement

Revenue (ttm)10.84k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-95.50%
Gross Profit (ttm)N/A
EBITDA -111.26k
Net Income Avi to Common (ttm)-4.23M
Diluted EPS (ttm)-0.0700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.3k
Total Cash Per Share (mrq)0
Total Debt (mrq)575.39k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.17
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-211.77k
Levered Free Cash Flow (ttm)45.73k